Rapid Reshore & Development (RR&D), an alliance of three specialized firms coming together to provide turnkey professional services for the life sciences and biopharmaceutical industries, has announced its official launch to address many of the logistical challenges facing companies developing drugs, vaccines and medical devices.
RR&D – comprised of Facility Logix, EwingCole and Biggins Lacy Shapiro & Co – will help companies maximize efficiency, minimize risk, and facilitate speed-to-market. The alliance represents an evolution from transaction-driven service models to a holistic focus on client needs, integrating an interdisciplinary team customized for a variety of individual projects.
“Our rapidly changing world created a multitude of challenges and opportunities across all industries,” said Jared Loos, PE, AIA, EwingCole’s CEO. “However, few face logistical obstacles like the life sciences and manufacturing sectors, including biopharmaceuticals, medical devices, medical equipment and their respective supply chains. Our goal was to create an alliance that can collaboratively and succinctly support their needs from start to finish.”
Life sciences and biopharmaceutical companies are pivoting to increase efficiency and capacity in record time, which requires quicker decision-making, identifying talent, retooling facilities, increasing capacity and shoring up resources.
“COVID-19 has created a greater need for these companies to establish and build out facilities, supply chains and other resources within a reduced timeframe,” said Jay Biggins, executive managing director Biggins Lacy Shapiro. “On top of the day-to-day development of life-saving therapies and technologies, this may result in an industry bottleneck. That’s where RR&D can assist.”
Click here to read more via Facility Logix